Wednesday, October 13, 2010

Antidepressant reboxetine no better than a placebo, study finds today

The study comes from the German Institute of Quality and Efficiency in Health Care. They’ve discovered that a famous and highly recommended antidepressant in the UK isn’t more effective than a placebo, even it could have dangerous consequences to the human health.
Scientists of the British Medical Journal said that Pfizer (Edronax's producer, the reboxetine pill) had hidden kind of the 74% of the test of the medicament, and just show to the market the 36% left, only the positive’s results!
In the US this medicament got denied the license in 2001 and Robert Steinbrook, an American scientific, tries to explain the situation.
"Companies have financial interests in the outcome of the studies they sponsor; they own the data, and set the rules for access to the data. Unfortunately, they cannot be relied on to consistently provide dispassionate evaluations of their own drugs and medical devices."

Also he supposed that some Scientifics and doctors may have financial links with Pfizer and the companies who distribute it
This situation can be useful to a sociologist as an example of the bad intentional collusion of the big enterprises and gives it the enough information to doubt about what a scientist says. They’re not angelical y pure people.
Read more...

1 comments:

Constanza Ureta said...

When I saw you writing this summary I wasn't sure why you were doing it, all I could do was read about medical stuff. You mentioned something about coluding. Now I get it. And as you mention this is an example of how the big hires which control our health can do it without any guilt, moved by money. Maybe even gettng to alter the way we're supposed to feel. This makes me think about the AH1N1 gripe which had us all worried last year and this year just seems to had stood still causing any harm...

Post a Comment